BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  Oxford BioTherapeutics announces Phase 1b trial in collaboration with GORTEC to investigate OBT076 in Adenoid Cystic Carcinoma (ACC) of the head and neck

  Oxford BioTherapeutics Ltd. announces it has entered into a collaboration with Groupe d’Oncologie Radiothérapie Tête Et Cou to undertake a new Phase 1b trial investigating OBT’s lead asset, OBT076, in patients with Adenoid Cystic Carcinoma.

  April 19, 2023

   · 

  5 min read
• MolecuLight Successfully Completes SOC 2® Type l Audit and Accreditation

  MolecuLight Inc. announced that it is in compliance with SOC 2® Type I, having successfully completed its audit in accordance with the American Institute of Certified Public Accountants standards for Systems and Organization Controls.

  April 19, 2023

   · 

  3 min read
• Genetown

  C4 Therapeutics to Participate in the Stifel 2023 Virtual Targeted Oncology Days

  C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC) today announced that C4T management will participate in a fireside chat at the Stifel 2023 Virtual Targeted Oncology Days.

  April 19, 2023

   · 

  1 min read
• Business

  STAAR Surgical to Report First Quarter Results on May 3, 2023

  STAAR Surgical Company today announced that it will release financial results for the first quarter ended March 31, 2023 on Wednesday, May 3, 2023 after the market close.

  April 19, 2023

   · 

  1 min read
• Business

  LifeStrands Genomics and Ambry Genetics to Provide Laboratory Testing for Clinical Implementation Pilots in Phase II of Singapore’s National Precision Medicine Programme

  LifeStrands Genomics and Ambry Genetics have joined forces to provide clinical genetic testing services in Singapore.

  April 19, 2023

   · 

  5 min read
• Biotech Beach

  Aurora Spine to Attend the American Association of Neurological Surgeons Annual Meeting

  Aurora Spine Corporation today announced that it will be attending the 2023 American Association of Neurological Surgeons (AANS) Annual Scientific Meeting.

  April 19, 2023

   · 

  4 min read
• Business

  Abbott Reports First-Quarter 2023 Results; Increases Outlook For Underlying Base Business

  Abbott (NYSE: ABT) today announced financial results for the first quarter ended March 31, 2023.

  April 19, 2023

   · 

  19 min read
• Drug Development

  Zucara Therapeutics Receives IND Clearance for Phase 2 Clinical Trial of ZT-01

  Zucara Therapeutics Inc., today announced that the U.S. Food and Drug Administration (“FDA”) has cleared the Company’s Investigational New Drug (“IND”) application for ZT-01 for the prevention of night-time (nocturnal) hypoglycemia in patients with Type 1 Diabetes (“T1D”).

  April 19, 2023

   · 

  3 min read
• Drug Development

  VYNE Therapeutics Announces Positive Preclinical Data for Inhaled Formulation of VYN201 in an In Vivo Model of Idiopathic Pulmonary Fibrosis

  VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced new preclinical data showing the positive effect of its novel pan-BET inhibitor, VYN201, in a preclinical model of idiopathic pulmonary fibrosis (“IPF”).

  April 19, 2023

   · 

  9 min read
• Pharm Country

  Indaptus Therapeutics Presents Data Demonstrating Preclinical Efficacy of Decoy, its Bacteria-Based Immunotherapy Platform Technology, at the American Association for Cancer Research Conference 2023

  Indaptus Therapeutics, Inc. today announces data presented in a poster at the American Association for Cancer Research (AACR) annual scientific conference on the Company’s Decoy anti-tumor platform.

  April 19, 2023

   · 

  8 min read